» Articles » PMID: 18927583

The Expanding Field of Poly(ADP-ribosyl)ation Reactions. 'Protein Modifications: Beyond the Usual Suspects' Review Series

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2008 Oct 18
PMID 18927583
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(ADP-ribosyl)ation is a post-translational modification of proteins that is mediated by poly(ADP-ribose) polymerases (PARPs). Although the existence and nature of the nucleic acid-like molecule poly(ADP-ribose) (PAR) has been known for 40 years, understanding its biological functions--originally thought to be only the regulation of chromatin superstructure when DNA is broken--is still the subject of intense research. Here, we review the mechanisms controlling the biosynthesis of this complex macromolecule and some of its main biological functions, with an emphasis on the most recent advances and hypotheses that have developed in this rapidly growing field.

Citing Articles

Novel heterozygous variant of causes pathogenic variation in CONDSIAS.

Yan S, Ren J, Su H, Ma J, He W, Cai X Heliyon. 2024; 10(14):e32945.

PMID: 39100487 PMC: 11295978. DOI: 10.1016/j.heliyon.2024.e32945.


Deltex family E3 ligases specifically ubiquitinate the terminal ADP-ribose of poly(ADP-ribosyl)ation.

Kelly M, Dietz C, Kasson S, Zhang Y, Holtzman M, Kim I Biochem Biophys Res Commun. 2024; 720:150101.

PMID: 38749191 PMC: 11219154. DOI: 10.1016/j.bbrc.2024.150101.


High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.

Dhakar S, Galera-Prat A, Lehtio L Sci Rep. 2024; 14(1):3875.

PMID: 38365924 PMC: 10873324. DOI: 10.1038/s41598-024-54123-8.


Development of PARP inhibitors in advanced prostate cancer.

Bourlon M, Valdez P, Castro E Ther Adv Med Oncol. 2024; 16:17588359231221337.

PMID: 38205078 PMC: 10777773. DOI: 10.1177/17588359231221337.


Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?.

Macchia G, Titone F, Restaino S, Arcieri M, Pellecchia G, Andreetta C Healthcare (Basel). 2023; 11(17).

PMID: 37685447 PMC: 10486999. DOI: 10.3390/healthcare11172413.


References
1.
Kauppinen T, Chan W, Suh S, Wiggins A, Huang E, Swanson R . Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc Natl Acad Sci U S A. 2006; 103(18):7136-41. PMC: 1459030. DOI: 10.1073/pnas.0508606103. View

2.
Midorikawa R, Takei Y, Hirokawa N . KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. Cell. 2006; 125(2):371-83. DOI: 10.1016/j.cell.2006.02.039. View

3.
Martin-Oliva D, Aguilar-Quesada R, OValle F, Munoz-Gamez J, Martinez-Romero R, Garcia Del Moral R . Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res. 2006; 66(11):5744-56. DOI: 10.1158/0008-5472.CAN-05-3050. View

4.
Juszczynski P, Kutok J, Li C, Mitra J, Aguiar R, Shipp M . BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol Cell Biol. 2006; 26(14):5348-59. PMC: 1592708. DOI: 10.1128/MCB.02351-05. View

5.
Schreiber V, Dantzer F, Ame J, de Murcia G . Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol. 2006; 7(7):517-28. DOI: 10.1038/nrm1963. View